Metformin, a common antidiabetic agent, has been reported with potent anti-cancer benefits via regulating multiple signaling pathways in cancer cells, including mammalian target of rapamycin (mTOR) signaling pathway [10]. The gene discussed is MTOR; the disease is cancer.